Gail Baura

Dr. Gail Baura

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1993 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
GBGail Baura
Gail Baura
DFD M Foster
D M Foster
DPD Porte
D Porte
SKS E Kahn
S E Kahn
RBR N Bergman
R N Bergman
MSM W Schwartz
M W Schwartz
By acting in the central nervous system, circulating insulin may regulate food intake and body weight. We have previously shown that the kinetics of insulin uptake from plasma into cerebrospinal fluid (CSF) can best be explained by passage through an intermediate compartment. To determine if transport kinetics into this compartment were consistent with an insulin receptor-mediated transport process, we subjected overnight fasted, anesthetized dogs to euglycemic intravenous insulin infusions for 90 min over a wide range of plasma insulin levels (69-5,064 microU/ml) (n = 10). Plasma and CSF samples were collected over 8 h for determination of immunoreactive insulin levels, and the kinetics of insulin uptake from plasma into CSF were analyzed using a compartmental model with three components (plasma-->intermediate compartment-->CSF). By sampling frequently during rapid changes of plasma and CSF insulin levels, we were able to precisely estimate three parameters (average standard deviation 14%) characterizing the uptake of insulin from plasma, through the intermediate compartment and into CSF (k1k2); insulin entry into CSF and insulin clearance from the intermediate compartment (k2 + k3); and insulin clearance from CSF (k4). At physiologic plasma insulin levels (80 +/- 7.4 microU/ml), k1k2 was determined to be 10.7 x 10(-6) +/- 1.3 x 10(-6) min-2. With increasing plasma levels, however, k1k2 decreased progressively, being reduced sevenfold at supraphysiologic levels (5,064 microU/ml). The apparent KM of this saturation curve was 742 microU/ml (approximately 5 nM). In contrast, the rate constants for insulin removal from the intermediate compartment and from CSF did not vary with plasma insulin (k2 + k3 = 0.011 +/- 0.0019 min-1 and k4 = 0.046 +/- 0.021 min-1). We conclude that delivery of plasma insulin into the central nervous system is saturable, and is likely facilitated by an insulin-receptor mediated transport process.

1 January 1996 in Diabetes
Verified
Journal Article
Closed access
PDF file
GBGail Baura
Gail Baura
DFDavid M. Foster
David M. Foster
KKKarl Kaiyala
Karl Kaiyala
DPDaniel Porte
Daniel Porte
SKSteven E Kahn
Steven E Kahn
MSMichael W Schwartz
Michael W Schwartz
We have previously shown that transport of plasma insulin into the central nervous system (CNS) is mediated by a saturable mechanism consistent with insulin binding to blood-brain barrier insulin receptors and subsequent transcytosis through microvessel endothelial cells. Since glucocorticoids antagonize insulin receptor-mediated actions both peripherally and in the CNS, we hypothesized that glucocorticoids also impair CNS insulin transport. Nine dogs were studied both in the control condition and after 7 days of high-dose oral dexamethasone (DEX) administration (12 mg/day) by obtaining plasma and cerebrospinal fluid (CSF) samples over 8 h for determination of immunoreactive insulin levels during a 90-min euglycemic intravenous insulin infusion (plasma insulin ∼700 pmol/l). From these data, the kinetics of CNS insulin uptake and removal were determined using a mathematical model with three components (plasma → intermediate compartment, hypothesized to be brain interstitial fluid → CSF). DEX increased basal insulin levels 75% from 24 ± 6 to 42 ± 30 pmol/l (P < 0.005) and slightly increased basal glucose levels from 5.0 ± 0.7 to 5.3 ± 1.0 mmol/l (P < 0.05). DEX also lowered the model rate constant characterizing CNS insulin transport by 49% from 5.3 × 10−6 ± 4.0 × 10−6 to 2.7 × 10−6 ± 1.2 × 10−6 min−2 (P ≤ 0.001). As glucocorticoids are known to reduce CSF turnover, we also hypothesized that the model rate constant associated with CSF insulin removal would be decreased by DEX. As expected, the model rate constant for CSF insulin removal decreased 47% from 0.038 ± 0.013 to 0.020 ± 0.088 min−1 (P ≤ 0.0005) during DEX treatment. We conclude that DEX impairs CNS insulin transport. This finding supports our hypothesis that insulin receptors participate in the CNS insulin transport process and that this process may be subject to regulation. Moreover, since increasing brain insulin transport reduces food intake and body adiposity, this observation provides a potential mechanism by which glucocorticoid excess leads to increased body adiposity.

7 May 2012 in Proceedings of the IEEE
Verified
Journal Article
Open access
MNMichael R. Neuman
Michael R. Neuman
GBGail Baura
Gail Baura
SMStuart Meldrum
Stuart Meldrum
OSOrhan Soykan
Orhan Soykan
MVMax E. Valentinuzzi
Max E. Valentinuzzi
YZYuan-Ting Zhang
Yuan-Ting Zhang
Medical devices and medical electronics are areas that had little to offer 100 years ago. However, there were three important existing technologies that led to many further developments over the following 100 years. These are the stethoscope, electrocardiography, and X-ray medical imaging. Although these technologies had been described and were available to some extent when the Proceedings of the IEEE pages first appeared, they had yet to achieve the widespread use that they have today. The stethoscope is the oldest of these, and it helped physicians to hear sounds of the body and relate them to functioning and malfunctioning organs. The early use of the stethoscope by physicians was more of an art than a science, but as the Proceedings matured, so did this technology. Engineers were able to make this a more quantitative process by graphically displaying the sounds and ultimately using techniques such as voiceprint analysis to assist the physician in diagnosis and monitoring of treatment. The electrocardiograph had been invented a few years prior to the appearance of the Proceedings, but the apparatus was awkward to use, especially for sick people, and was considered more of an oddity than a viable medical technology 100 years ago. Today, it and devices derived from it such as cardiac patient monitors are important parts of our healthcare system. Similarly, X-rays represented a new technology 100 years ago, but unlike electrocardiography physicians immediately saw the value of this technology and quickly adopted it. Many improvements have been made to the basic technology over the last 100 years culminating in computer tomography and complex image processing. Other devices to create high-quality and 3-D medical images have also been developed in recent years to make medical imaging a very important aspect of clinical care today. Looking to the future is always a difficult task, but it is clear that the electronic health record will play an important role in consolidating the information from various medical devices as well as providing readily available data on patients wherever it might be needed. Future medical devices will need to not only address the problems of diagnostic and therapeutic medicine but also be capable of addressing important societal problems such as worldwide disparities in the availability of medical care, continually rising healthcare costs, and healthcare for travel beyond Earth. The next 100 years promises to be even more exciting than the last from the perspective of medical devices and medical electronics.


1 January 2008 in Synthesis Lectures on Biomedical Engineering
Verified
Journal Article
Closed access
GBGail Baura
Gail Baura
A medical device is an apparatus that uses engineering and scientific principles to interface to physiology and diagnose or treat a disease. In this Lecture, we specifically consider thosemedical devices that are computer based, and are therefore referred to as medical instruments. Further, the medical instruments we discuss are those that incorporate system theory into their designs. We divide these types of instruments into those that provide continuous observation and those that provide a single snapshot of health information. These instruments are termed patient monitoring devices and diagnostic devices, respectively.Within this Lecture, we highlight some of the common system theory techniques that are part of the toolkit of medical device engineers in industry. These techniques include the pseudorandom binary sequence, adaptive filtering, wavelet transforms, the autoregressive moving average model with exogenous input, artificial neural networks, fuzzy models, and fuzzy control. Because the ...